Literature DB >> 15454343

Link between free radicals and protein kinase C in glucose-induced alteration of vascular dilation.

Momoh A Yakubu1, Olusoga A Sofola, Immaculata Igbo, Adebayo O Oyekan.   

Abstract

Development of vascular complications in diabetes has been linked to the quality of glucose regulation and characterized by endothelial dysfunction. The exact mechanism behind vascular complications in diabetes is poorly understood. However, alteration of nitric oxide (NO) biosynthesis or bioactivity is strongly implicated and the mechanism behind such alterations is still a subject for research investigations. In the present study, we tested the hypothesis that glucose-induced attenuation of vascular relaxation involves protein kinase C (PKC)-linked generation of free radicals. Vascular relaxation to acetylcholine (ACh; 10(-9)-10(-5) M), isoproterenol (10(-9)-10(-5) M), or NO donor, sodium nitropruside (SNP; 10(-9)-10(-6) M) was determined in phenylephrine (PE, 10(-7) M) pre-constricted aortic rings from Sprague-Dawley rats in the presence or absence of 30 mM glucose (30 min), L-nitro-arginine methyl ester (L-NAME; 10(-4) M for 15 min), a NO synthase inhibitor, or xanthine (10(-5) M), a free radical generator. ACh dose-dependently caused relaxation that was attenuated by L-NAME, glucose, or xanthine. Pre-incubation (15 min) of the rings with vitamin C (10(-4) M), an antioxidant or calphostin C (10(-6) M), a PKC inhibitor, restored the ACh responses. However, high glucose had no significant effects on SNP or isoproterenol-induced relaxation. ACh-induced NO production by aortic ring was significantly reduced by glucose or xanthine. The reduced NO production was restored by pretreatment with vitamin C or calphostin C in the presence of glucose, but not xanthine. These data demonstrate that oxidants or PKC contribute to glucose-induced attenuation of vasorelaxation which could be mediated via impaired endothelial NO production and bioavailability. Thus, pathogenesis of glucose-induced vasculopathy involves PKC-coupled generation of oxygen free radicals which inhibit NO production and selectively inhibit NO-dependent relaxation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15454343      PMCID: PMC2922949          DOI: 10.1016/j.lfs.2004.05.019

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  23 in total

1.  Elevated glucose impairs endothelium-dependent relaxation by activating protein kinase C.

Authors:  B Tesfamariam; M L Brown; R A Cohen
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

Review 2.  Nitric oxide: physiology, pathophysiology, and pharmacology.

Authors:  S Moncada; R M Palmer; E A Higgs
Journal:  Pharmacol Rev       Date:  1991-06       Impact factor: 25.468

Review 3.  Endothelial cells in physiology and in the pathophysiology of vascular disorders.

Authors:  D B Cines; E S Pollak; C A Buck; J Loscalzo; G A Zimmerman; R P McEver; J S Pober; T M Wick; B A Konkle; B S Schwartz; E S Barnathan; K R McCrae; B A Hug; A M Schmidt; D M Stern
Journal:  Blood       Date:  1998-05-15       Impact factor: 22.113

4.  Vascular effects of acute hyperglycemia in humans are reversed by L-arginine. Evidence for reduced availability of nitric oxide during hyperglycemia.

Authors:  D Giugliano; R Marfella; L Coppola; G Verrazzo; R Acampora; R Giunta; F Nappo; C Lucarelli; F D'Onofrio
Journal:  Circulation       Date:  1997-04-01       Impact factor: 29.690

Review 5.  Dysfunction of the endothelial nitric oxide signalling pathway in diabetes and hyperglycaemia.

Authors:  L Sobrevia; G E Mann
Journal:  Exp Physiol       Date:  1997-05       Impact factor: 2.969

Review 6.  Endothelium-dependent hyperpolarization. Beyond nitric oxide and cyclic GMP.

Authors:  R A Cohen; P M Vanhoutte
Journal:  Circulation       Date:  1995-12-01       Impact factor: 29.690

Review 7.  Oxidative stress and diabetic vascular complications.

Authors:  D Giugliano; A Ceriello; G Paolisso
Journal:  Diabetes Care       Date:  1996-03       Impact factor: 19.112

8.  High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells.

Authors:  F Cosentino; K Hishikawa; Z S Katusic; T F Lüscher
Journal:  Circulation       Date:  1997-07-01       Impact factor: 29.690

9.  Selective impairment of acetylcholine-mediated endothelium-dependent relaxation in isolated resistance arteries of the streptozotocin-induced diabetic rat.

Authors:  P D Taylor; J E Graves; L Poston
Journal:  Clin Sci (Lond)       Date:  1995-05       Impact factor: 6.124

10.  Effects of haemoglobin and N-nitro-L-arginine on constrictor and dilator responses of aortic rings from streptozotocin diabetic rats.

Authors:  B W Sikorski; W C Hodgson; R G King
Journal:  Eur J Pharmacol       Date:  1993-10-05       Impact factor: 4.432

View more
  4 in total

1.  Differential inhibition by hyperglycaemia of shear stress- but not acetylcholine-mediated dilatation in the iliac artery of the anaesthetized pig.

Authors:  R Kelly; T Ruane-O'Hora; M I M Noble; A J Drake-Holland; H M Snow
Journal:  J Physiol       Date:  2006-03-16       Impact factor: 5.182

2.  Endothelin-1 impairs nitric oxide signaling in endothelial cells through a protein kinase Cdelta-dependent activation of STAT3 and decreased endothelial nitric oxide synthase expression.

Authors:  Neetu Sud; Stephen M Black
Journal:  DNA Cell Biol       Date:  2009-11       Impact factor: 3.311

3.  Differential modulation of bradykinin-induced relaxation of endothelin-1 and phenylephrine contractions of rat aorta by antioxidants.

Authors:  Ogechukwu Anozie; Richonda Ross; Adebayo O Oyekan; Momoh A Yakubu
Journal:  Acta Pharmacol Sin       Date:  2007-10       Impact factor: 6.150

4.  Modulation of PKCdelta signaling alters the shear stress-mediated increases in endothelial nitric oxide synthase transcription: role of STAT3.

Authors:  Neetu Sud; Sanjiv Kumar; Stephen Wedgwood; Stephen M Black
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-12-31       Impact factor: 5.464

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.